Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GDUFA: Fee Avoidance Affects Rates Again

Aug 12 2013

• By Derrick Gingery

Related Content

Drug Review Personnel Costs Dropping, Remain “Completely Normal,” FDA Says

Aug 12 2013

FDA User Fees In FY 2014: Burden Per Application Grows As Submission Projections Fall

Aug 05 2013

Backlog Backfire: FDA Sees Increase In Pending Generic Applications At Deadline

Oct 15 2012

ANDA Sponsors May Need Extra Three Months To Avoid DMF-Related Delays

Oct 15 2012

GDUFA Self-Identification Woes Can’t Deflate Industry, FDA Enthusiasm

Dec 17 2012

Generic User Fees Need Small Business Waiver, Firms Say; Congress May Agree

Jun 24 2013

Generic User Fee Agreement Includes FDA Pledge To Determine Best Use Of Foreign Regulator Inspections

Dec 07 2011

GDUFA Launch Pains: Facility List Fluctuations, Back-Due Backlog Fees

Feb 18 2013

Additional Topics

United States Regulation Post Market Regulation & Studies BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window